Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.
- Low-dose cytosine arabinoside
- Pneumocystis carinii pneumonia
- Sweet's syndrome
ASJC Scopus subject areas